TrialThe Journal of clinical endocrinology and metabolism2020

Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids.

Nantia Othonos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.